HEALTH TIPS.: NIH researchers make progress toward Epstein-Barr virus (EBV) vaccine, with novel vaccine candidates that, in animals, elicited potent anti-EBV antibody responses that blocked infection of cell types involved in EBV-associated cancers. Worldwide, EBV-associated cancers results in 140,000 deaths.

Saturday, 20 April 2019

NIH researchers make progress toward Epstein-Barr virus (EBV) vaccine, with novel vaccine candidates that, in animals, elicited potent anti-EBV antibody responses that blocked infection of cell types involved in EBV-associated cancers. Worldwide, EBV-associated cancers results in 140,000 deaths.

submitted by /u/mvea
[link] [comments]

from Health http://bit.ly/2XtD7Y4
via IFTTT

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)